Cargando…
Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma
BACKGROUNDS AND AIMS: Because of the known limitations of ultrasonography (US) alone, we re-evaluated whether complimentary testing for serum alpha-fetoprotein (AFP) is helpful in surveilling for hepatocellular carcinoma (HCC) in high-risk populations. METHODS: We included, from a hospital-based can...
Autores principales: | An, Jihyun, Kim, Ha Il, Chang, Seheon, Shim, Ju Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449471/ https://www.ncbi.nlm.nih.gov/pubmed/32845895 http://dx.doi.org/10.1371/journal.pone.0238078 |
Ejemplares similares
-
The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease
por: An, Jihyun, et al.
Publicado: (2019) -
The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia
por: Jasirwan, Chyntia Olivia Maurine, et al.
Publicado: (2020) -
Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022) -
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018) -
Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019)